Science Applications International (SAIC) Financials

$105.32 +2.87 (+2.80%)

As of 06/6/2025

Annual Income Statements for Science Applications International

This table shows Science Applications International's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	1/30/2015	1/29/2016	2/3/2017	2/2/2018	2/1/2019	1/31/2020	1/29/2021	1/28/2022	2/3/2023	2/2/2024	1/31/2025
Net Income / (Loss) Attributable to Common Shareholders	141	117	143	179	137	226	209	277	300	477	362
Consolidated Net Income / (Loss)	141	117	143	179	137	229	211	279	303	477	362
Net Income / (Loss) Continuing Operations	141	117	143	179	137	229	211	279	303	477	362
Total Pre-Tax Income	223	183	212	214	170	286	271	358	375	620	428
Total Operating Income	240	227	263	256	220	370	390	462	501	741	563
Total Gross Profit	335	411	439	411	464	706	792	859	888	872	892
Total Revenue	3,885	4,315	4,442	4,454	4,659	6,379	7,056	7,394	7,704	7,444	7,479
Operating Revenue	3,885	4,315	4,442	4,454	4,659	6,379	7,056	7,394	7,704	7,444	7,479
Total Cost of Revenue	3,550	3,904	4,003	4,043	4,195	5,673	6,264	6,535	6,816	6,572	6,587
Operating Cost of Revenue	3,550	3,904	4,003	4,043	4,195	5,673	6,264	6,535	6,816	6,572	6,587
Total Operating Expenses	95	184	176	155	244	336	402	397	387	131	329
Selling, General & Admin Expense	95	184	166	155	158	288	352	344	374	373	339
Other Operating Expenses / (Income)	-	-	-	-	0.00	0.00	-4.00	-1.00	13	-2.00	-10
Other Special Charges / (Income)	-	-	-	-	-	-	-	-2.00	0.00	-240	0.00
Total Other Income / (Expense), net	-17	-44	-51	-42	-50	-84	-119	-104	-126	-121	-135
Interest Expense	17	44	52	44	53	90	122	105	118	120	126
Other Income / (Expense), net	0.00	0.00	1.00	2.00	3.00	6.00	3.00	1.00	-8.00	-1.00	-9.00
Income Tax Expense	82	66	69	35	33	57	60	79	72	143	66
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	0.00	0.00	0.00	3.00	2.00	2.00	3.00	0.00	0.00
Basic Earnings per Share	$3.01	$2.55	$3.21	$4.13	$3.16	$3.87	$3.60	$4.81	$5.42	$8.98	$7.23
Weighted Average Basic Shares Outstanding	46.90M	45.90M	43.57M	43.30M	59.32M	57.84M	58.07M	56.05M	54.20M	51.65M	47.74M
Diluted Earnings per Share	$2.91	$2.47	$3.12	$4.02	$3.11	$3.83	$3.56	$4.77	$5.38	$8.88	$7.17
Weighted Average Diluted Shares Outstanding	46.90M	45.90M	43.57M	43.30M	59.32M	57.84M	58.07M	56.05M	54.20M	51.65M	47.74M
Weighted Average Basic & Diluted Shares Outstanding	46.90M	45.90M	43.57M	43.30M	59.32M	57.84M	58.07M	56.05M	54.20M	51.65M	47.74M
Cash Dividends to Common per Share	$1.28	$1.21	$1.24	$1.24	$1.24	$1.48	$1.48	$1.48	$1.48	$1.48	$1.48

This table shows Science Applications International's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	7/29/2022	10/28/2022	2/3/2023	5/5/2023	8/4/2023	11/3/2023	2/2/2024	5/3/2024	8/2/2024	11/1/2024	1/31/2025
Net Income / (Loss) Attributable to Common Shareholders	73	80	74	98	247	93	39	77	81	106	98
Consolidated Net Income / (Loss)	74	80	75	98	247	93	39	77	81	106	98
Net Income / (Loss) Continuing Operations	74	80	75	98	247	93	39	77	81	106	98
Total Pre-Tax Income	95	100	85	123	335	114	48	95	100	126	107
Total Operating Income	125	133	118	157	362	143	79	131	134	160	138
Total Gross Profit	219	221	222	235	216	229	192	213	210	237	232
Total Revenue	1,831	1,909	1,968	2,028	1,784	1,895	1,737	1,847	1,818	1,976	1,838
Operating Revenue	1,831	1,909	1,968	2,028	1,784	1,895	1,737	1,847	1,818	1,976	1,838
Total Cost of Revenue	1,612	1,688	1,746	1,793	1,568	1,666	1,545	1,634	1,608	1,739	1,606
Operating Cost of Revenue	1,612	1,688	1,746	1,793	1,568	1,666	1,545	1,634	1,608	1,739	1,606
Total Operating Expenses	94	88	104	78	-146	86	113	82	76	77	94
Selling, General & Admin Expense	93	87	102	84	88	87	114	85	77	83	94
Total Other Income / (Expense), net	-30	-33	-33	-34	-27	-29	-31	-36	-34	-34	-31
Interest Expense	30	30	31	32	29	27	32	34	31	32	29
Other Income / (Expense), net	0.00	-3.00	-2.00	-2.00	2.00	-2.00	1.00	-2.00	-3.00	-2.00	-2.00
Income Tax Expense	21	20	10	25	88	21	9.00	18	19	20	9.00
Basic Earnings per Share	$1.31	$1.45	$1.36	$1.80	$4.60	$1.79	$0.79	$1.49	$1.59	$2.15	$2.00
Weighted Average Basic Shares Outstanding	55.13M	54.63M	54.20M	53.68M	52.94M	52.06M	51.65M	51.23M	49.52M	48.88M	47.74M
Diluted Earnings per Share	$1.30	$1.45	$1.34	$1.79	$4.56	$1.76	$0.77	$1.48	$1.58	$2.13	$1.98
Weighted Average Diluted Shares Outstanding	55.13M	54.63M	54.20M	53.68M	52.94M	52.06M	51.65M	51.23M	49.52M	48.88M	47.74M
Weighted Average Basic & Diluted Shares Outstanding	55.13M	54.63M	54.20M	53.68M	52.94M	52.06M	51.65M	51.23M	49.52M	48.88M	47.74M

This table details how cash moves in and out of Science Applications International's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	1/30/2015	1/29/2016	2/3/2017	2/2/2018	2/1/2019	1/31/2020	1/29/2021	1/28/2022	2/3/2023	2/2/2024	1/31/2025
Net Change in Cash & Equivalents	47	-92	9.00	-66	94	-44	-12	-75	3.00	-15	-39
Net Cash From Operating Activities	277	226	273	217	184	458	755	518	532	396	494
Net Cash From Continuing Operating Activities	277	226	273	217	184	458	755	518	532	396	494
Net Income / (Loss) Continuing Operations	141	117	143	179	137	229	211	279	303	477	362
Consolidated Net Income / (Loss)	141	117	143	179	137	229	211	279	303	477	362
Depreciation Expense	21	62	53	46	47	131	179	165	157	142	140
Non-Cash Adjustments To Reconcile Net Income	32	24	16	27	85	42	54	62	47	-185	46
Changes in Operating Assets and Liabilities, net	83	23	61	-35	-87	49	305	38	25	-38	-54
Net Cash From Investing Activities	-22	-784	-17	-22	-1,028	-47	-1,231	-292	-36	314	-35
Net Cash From Continuing Investing Activities	-22	-784	-17	-22	-1,028	-47	-1,231	-292	-36	314	-35
Purchase of Property, Plant & Equipment	-22	-20	-15	-22	-28	-21	-46	-36	-25	-27	-36
Acquisitions	0.00	-764	0.00	0.00	-1,001	0.00	-1,202	-255	0.00	-8.00	0.00
Purchase of Investments	-	-	-	0.00	0.00	-24	-6.00	-9.00	-7.00	-8.00	-14
Divestitures	-	-	-	-	0.00	0.00	17	8.00	0.00	356	10
Sale and/or Maturity of Investments	-	-	-	0.00	0.00	3.00	9.00	6.00	4.00	6.00	12
Other Investing Activities, net	0.00	-	-2.00	0.00	1.00	-5.00	-3.00	-6.00	-8.00	-5.00	-7.00
Net Cash From Financing Activities	-208	466	-247	-261	938	-455	464	-301	-493	-725	-498
Net Cash From Continuing Financing Activities	-208	466	-247	-261	938	-455	464	-301	-493	-725	-498
Repayment of Debt	-13	-89	-238	-50	-805	-274	-426	-119	-999	-441	-1,384
Repurchase of Common Equity	-149	-69	-180	-186	-71	-197	-34	-226	-267	-382	-558
Payment of Dividends	-52	-55	-54	-54	-52	-94	-89	-88	-83	-79	-75
Issuance of Debt	0.00	670	209	25	1,859	100	1,000	116	840	160	1,499
Issuance of Common Equity	3.00	4.00	5.00	6.00	7.00	10	13	16	16	17	20
Cash Interest Paid	17	36	48	41	44	86	96	98	111	125	121
Cash Income Taxes Paid	49	53	46	31	24	32	39	7.00	70	165	66

This table details how cash moves in and out of Science Applications International's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	7/29/2022	10/28/2022	2/3/2023	5/5/2023	8/4/2023	11/3/2023	2/2/2024	5/3/2024	8/2/2024	11/1/2024	1/31/2025
Net Change in Cash & Equivalents	43	-46	56	313	-70	-41	-217	-45	-2.00	-2.00	10
Net Cash From Operating Activities	141	128	145	82	150	101	63	98	138	143	115
Net Cash From Continuing Operating Activities	141	128	145	84	148	101	63	100	136	143	115
Net Income / (Loss) Continuing Operations	74	80	75	98	247	93	39	77	81	106	98
Consolidated Net Income / (Loss)	74	80	75	98	247	93	39	77	81	106	98
Depreciation Expense	40	37	39	36	36	34	36	35	34	35	36
Non-Cash Adjustments To Reconcile Net Income	12	12	12	6.00	-229	14	24	14	8.00	7.00	17
Changes in Operating Assets and Liabilities, net	15	3.00	15	-56	94	-40	-36	-26	13	-5.00	-36
Net Cash From Investing Activities	-11	-6.00	-13	336	-2.00	-10	-10	-7.00	-9.00	1.00	-20
Net Cash From Continuing Investing Activities	-11	-6.00	-13	336	-2.00	-10	-10	-7.00	-9.00	1.00	-20
Purchase of Property, Plant & Equipment	-7.00	-6.00	-7.00	-6.00	-6.00	-4.00	-11	-6.00	-6.00	-9.00	-15
Purchase of Investments	-2.00	-1.00	-2.00	-3.00	-2.00	-1.00	-2.00	-4.00	-4.00	-3.00	-3.00
Sale and/or Maturity of Investments	1.00	1.00	1.00	1.00	3.00	1.00	1.00	4.00	2.00	4.00	2.00
Other Investing Activities, net	-3.00	-	-5.00	-3.00	-	-7.00	5.00	-1.00	-1.00	-1.00	-4.00
Net Cash From Financing Activities	-87	-168	-76	-105	-218	-132	-270	-136	-131	-146	-85
Net Cash From Continuing Financing Activities	-87	-168	-76	-105	-218	-132	-270	-136	-131	-146	-85
Repayment of Debt	-521	-206	-213	-160	-100	-15	-166	-310	-296	-450	-328
Repurchase of Common Equity	-64	-60	-59	-88	-102	-103	-89	-103	-201	-121	-133
Payment of Dividends	-21	-21	-18	-21	-20	-19	-19	-20	-19	-18	-18
Issuance of Debt	515	115	210	160	-	-	-	293	380	441	385
Issuance of Common Equity	4.00	4.00	4.00	4.00	4.00	5.00	4.00	4.00	5.00	5.00	6.00

This table presents Science Applications International's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	1/30/2015	1/29/2016	2/3/2017	2/2/2018	2/1/2019	1/31/2020	1/29/2021	1/28/2022	2/3/2023	2/2/2024	1/31/2025
Total Assets	1,389	2,122	2,042	784	4,563	4,711	5,723	5,746	5,543	5,314	5,246
Total Current Assets	942	952	901	753	1,433	1,430	1,289	1,263	1,197	1,131	1,154
Cash & Equivalents	301	195	210	-	237	188	171	106	109	94	56
Accounts Receivable	544	635	539	673	1,050	1,099	962	1,015	936	914	1,000
Prepaid Expenses	20	21	27	-	47	40	56	57	58	93	78
Other Current Assets	10	33	54	14	25	19	22	21	23	30	20
Plant, Property, & Equipment, net	59	71	60	0.00	103	91	108	100	92	91	104
Total Noncurrent Assets	388	1,099	1,081	31	3,027	3,190	4,326	4,383	4,254	4,092	3,988
Goodwill	379	860	863	-	2,120	2,139	2,787	2,913	2,911	2,851	2,851
Intangible Assets	2.00	224	200	-	803	711	1,138	1,132	1,009	894	779
Other Noncurrent Operating Assets	7.00	15	18	31	104	340	401	338	320	347	358
Total Liabilities & Shareholders' Equity	1,389	2,122	2,042	491	4,563	4,711	5,723	5,746	5,543	5,314	5,246
Total Liabilities	1,044	1,742	1,693	165	3,064	3,284	4,171	4,117	3,839	3,529	3,669
Total Current Liabilities	552	688	623	94	897	1,128	1,275	1,352	1,126	1,158	1,396
Short-Term Debt	32	57	25	-	24	70	68	148	31	77	313
Accounts Payable	315	351	329	-	455	527	517	612	624	567	631
Accrued Expenses	205	280	269	94	297	405	494	365	266	265	233
Current Employee Benefit Liabilities	-	-	-	-	121	126	196	227	205	249	219
Total Noncurrent Liabilities	492	1,054	1,070	71	2,167	2,156	2,896	2,765	2,713	2,371	2,273
Long-Term Debt	454	1,013	1,022	-	2,065	1,851	2,447	2,370	2,343	2,022	1,907
Noncurrent Deferred & Payable Income Tax Liabilities	19	8.00	10	24	-	-	2.00	43	0.00	28	24
Other Noncurrent Operating Liabilities	19	33	38	47	102	305	447	352	370	321	342
Commitments & Contingencies	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	345	380	349	326	1,499	1,427	1,552	1,629	1,704	1,785	1,577
Total Preferred & Common Equity	345	380	349	326	1,485	1,417	1,542	1,619	1,694	1,785	1,577
Total Common Equity	345	380	349	326	1,485	1,417	1,542	1,619	1,694	1,785	1,577
Common Stock	234	215	91	-	1,132	983	1,004	838	637	337	0.00
Retained Earnings	116	174	260	326	367	506	627	818	1,035	1,432	1,565
Accumulated Other Comprehensive Income / (Loss)	-5.00	-9.00	-2.00	-	-14	-72	-89	-37	22	16	12

This table presents Science Applications International's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	10/29/2021	4/29/2022	7/29/2022	10/28/2022	5/5/2023	8/4/2023	11/3/2023	5/3/2024	8/2/2024	11/1/2024
Total Assets	5,916	5,716	5,654	5,628	5,957	5,672	5,658	5,250	5,250	5,275
Total Current Assets	1,383	1,291	1,270	1,247	1,675	1,384	1,388	1,091	1,103	1,160
Cash & Equivalents	148	56	99	53	422	352	311	49	48	46
Accounts Receivable	1,107	1,104	1,036	1,059	995	958	1,010	934	946	1,022
Prepaid Expenses	128	131	135	135	77	74	67	108	109	92
Plant, Property, & Equipment, net	103	97	95	95	91	90	89	93	95	99
Total Noncurrent Assets	4,430	4,328	4,289	4,286	4,191	4,198	4,181	4,066	4,052	4,016
Goodwill	2,905	2,911	2,911	2,911	2,851	2,851	2,851	2,851	2,851	2,851
Intangible Assets	1,166	1,101	1,069	1,040	980	951	923	865	836	807
Other Noncurrent Operating Assets	359	316	309	335	360	396	407	350	365	358
Total Liabilities & Shareholders' Equity	5,916	5,716	5,654	5,628	5,957	5,672	5,658	5,250	5,250	5,275
Total Liabilities	4,271	4,066	4,001	3,932	4,265	3,829	3,830	3,491	3,625	3,663
Total Current Liabilities	1,395	1,334	1,190	1,230	1,553	1,212	1,226	1,154	1,292	1,337
Short-Term Debt	119	119	0.00	15	46	62	69	90	197	220
Accounts Payable	877	820	853	819	809	820	840	648	639	714
Accrued Expenses	-	-	-	-	-	-	-	129	118	92
Current Employee Benefit Liabilities	399	395	337	396	277	330	317	287	338	311
Total Noncurrent Liabilities	2,876	2,732	2,811	2,702	2,712	2,617	2,604	2,337	2,333	2,326
Long-Term Debt	2,433	2,342	2,462	2,358	2,329	2,215	2,194	1,993	1,970	1,939
Noncurrent Deferred & Payable Income Tax Liabilities	-	45	7.00	0.00	-	-	-	29	19	12
Other Noncurrent Operating Liabilities	443	345	342	344	383	402	410	315	344	375
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,645	1,650	1,653	1,696	1,692	1,843	1,828	1,759	1,625	1,612
Total Preferred & Common Equity	1,635	1,640	1,643	1,686	1,692	1,843	1,828	1,759	1,625	1,612
Total Common Equity	1,635	1,640	1,643	1,686	1,692	1,843	1,828	1,759	1,625	1,612
Common Stock	896	770	723	679	563	480	395	251	63	0.00
Retained Earnings	796	870	923	981	1,113	1,340	1,413	1,489	1,551	1,602
Accumulated Other Comprehensive Income / (Loss)	-57	0.00	-3.00	26	16	23	20	19	11	10

This table displays calculated financial ratios and metrics derived from Science Applications International's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	1/30/2015	1/29/2016	2/3/2017	2/2/2018	2/1/2019	1/31/2020	1/29/2021	1/28/2022	2/3/2023	2/2/2024	1/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-5.73%	11.07%	2.94%	0.27%	4.60%	36.92%	10.61%	4.79%	4.19%	-3.37%	0.47%
EBITDA Growth	33.16%	10.73%	9.69%	-4.10%	-10.53%	88.97%	12.45%	4.15%	7.97%	35.69%	-21.32%
EBIT Growth	31.15%	-5.42%	16.30%	-2.27%	-13.57%	68.61%	4.52%	17.81%	6.48%	50.10%	-25.14%
NOPAT Growth	29.15%	-4.36%	22.23%	20.70%	-17.20%	67.10%	2.50%	18.57%	12.43%	40.83%	-16.47%
Net Income Growth	24.78%	-17.02%	22.22%	25.17%	-23.46%	67.15%	-7.86%	32.23%	8.60%	57.43%	-24.11%
EPS Growth	28.19%	-15.12%	26.32%	28.85%	-22.64%	23.15%	-7.05%	33.99%	12.79%	65.06%	-19.26%
Operating Cash Flow Growth	51.37%	-18.41%	20.80%	-20.51%	-15.21%	148.91%	64.85%	-31.39%	2.70%	-25.56%	24.75%
Free Cash Flow Firm Growth	172.67%	-335.00%	142.49%	-21.62%	-1,118.33%	124.78%	-188.73%	149.74%	121.72%	57.11%	-29.89%
Invested Capital Growth	-15.20%	136.79%	-5.50%	1.77%	177.63%	-5.70%	23.29%	3.72%	-1.78%	-4.51%	-1.29%
Revenue Q/Q Growth	0.28%	2.84%	-1.18%	2.53%	1.39%	5.77%	2.57%	0.89%	2.47%	-3.01%	1.37%
EBITDA Q/Q Growth	1.95%	3.58%	-2.46%	4.11%	-16.05%	26.60%	4.71%	-4.44%	5.86%	-4.23%	8.78%
EBIT Q/Q Growth	1.27%	-2.16%	0.00%	4.45%	-19.78%	27.89%	3.97%	-4.54%	7.17%	-4.64%	11.25%
NOPAT Q/Q Growth	2.08%	-1.41%	0.80%	12.32%	-25.38%	34.55%	0.76%	-3.76%	10.35%	-6.40%	15.06%
Net Income Q/Q Growth	2.17%	-6.40%	2.14%	12.58%	-30.46%	43.13%	0.48%	-5.74%	11.40%	-7.02%	19.47%
EPS Q/Q Growth	3.19%	-5.73%	2.97%	13.24%	-31.35%	49.61%	1.14%	-5.73%	12.08%	-6.03%	20.30%
Operating Cash Flow Q/Q Growth	-9.48%	5.61%	-14.42%	11.28%	-25.20%	11.44%	-2.08%	10.68%	8.57%	-17.15%	11.76%
Free Cash Flow Firm Q/Q Growth	138.78%	-298.44%	-16.76%	18.74%	-1,033.82%	128.87%	-8.19%	13.72%	19.25%	-11.35%	12.01%
Invested Capital Q/Q Growth	-63.82%	-4.92%	-1.17%	-1.71%	167.01%	-0.09%	0.83%	-0.20%	-1.17%	0.26%	0.43%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	8.62%	9.52%	9.88%	9.23%	9.96%	11.07%	11.22%	11.62%	11.53%	11.71%	11.93%
EBITDA Margin	6.72%	6.70%	7.14%	6.83%	5.84%	8.06%	8.19%	8.14%	8.44%	11.85%	9.28%
Operating Margin	6.18%	5.26%	5.92%	5.75%	4.72%	5.80%	5.53%	6.25%	6.50%	9.95%	7.53%
EBIT Margin	6.18%	5.26%	5.94%	5.79%	4.79%	5.89%	5.57%	6.26%	6.40%	9.94%	7.41%
Profit (Net Income) Margin	3.63%	2.71%	3.22%	4.02%	2.94%	3.59%	2.99%	3.77%	3.93%	6.41%	4.84%
Tax Burden Percent	63.23%	63.93%	67.45%	83.64%	80.59%	80.07%	77.86%	77.93%	80.80%	76.94%	84.58%
Interest Burden Percent	92.92%	80.62%	80.30%	82.95%	76.23%	76.06%	68.96%	77.32%	76.06%	83.78%	77.26%
Effective Tax Rate	36.77%	36.07%	32.55%	16.36%	19.41%	19.93%	22.14%	22.07%	19.20%	23.06%	15.42%
Return on Invested Capital (ROIC)	26.28%	16.26%	14.54%	17.90%	7.78%	9.10%	8.61%	9.07%	10.11%	14.70%	12.65%
ROIC Less NNEP Spread (ROIC-NNEP)	21.31%	10.95%	10.52%	13.80%	4.83%	5.35%	4.06%	5.66%	5.75%	10.33%	7.17%
Return on Net Nonoperating Assets (RNNOA)	12.78%	16.01%	24.70%	35.06%	7.23%	6.55%	5.56%	8.47%	8.07%	12.65%	8.89%
Return on Equity (ROE)	39.06%	32.28%	39.23%	52.96%	15.01%	15.65%	14.17%	17.54%	18.18%	27.34%	21.53%
Cash Return on Invested Capital (CROIC)	42.73%	-64.97%	20.19%	16.14%	-86.30%	14.97%	-12.25%	5.42%	11.91%	19.31%	13.95%
Operating Return on Assets (OROA)	16.93%	12.93%	12.68%	12.54%	6.72%	8.11%	7.53%	8.07%	8.73%	13.63%	10.49%
Return on Assets (ROA)	9.94%	6.66%	6.87%	8.70%	4.13%	4.94%	4.04%	4.87%	5.37%	8.79%	6.86%
Return on Common Equity (ROCE)	39.06%	32.28%	39.23%	52.96%	14.89%	15.52%	14.07%	17.43%	18.07%	27.26%	21.53%
Return on Equity Simple (ROE_SIMPLE)	40.87%	30.79%	40.97%	54.74%	9.23%	16.16%	13.68%	17.23%	17.89%	26.72%	22.96%
Net Operating Profit after Tax (NOPAT)	152	145	177	214	177	296	304	360	405	570	476
NOPAT Margin	3.91%	3.36%	3.99%	4.81%	3.81%	4.64%	4.30%	4.87%	5.25%	7.66%	6.37%
Net Nonoperating Expense Percent (NNEP)	4.96%	5.31%	4.02%	4.09%	2.95%	3.75%	4.55%	3.41%	4.35%	4.36%	5.48%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	9.93%	14.68%	12.54%
Cost of Revenue to Revenue	91.38%	90.48%	90.12%	90.77%	90.04%	88.93%	88.78%	88.38%	88.47%	88.29%	88.07%
SG&A Expenses to Revenue	2.45%	4.26%	3.74%	3.48%	3.39%	4.51%	4.99%	4.65%	4.85%	5.01%	4.53%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	2.45%	4.26%	3.96%	3.48%	5.24%	5.27%	5.70%	5.37%	5.02%	1.76%	4.40%
Earnings before Interest and Taxes (EBIT)	240	227	264	258	223	376	393	463	493	740	554
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	261	289	317	304	272	514	578	602	650	882	694
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	5.47	4.43	9.21	8.80	1.77	3.33	3.44	2.76	3.27	3.72	3.36
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.49	0.39	0.72	0.65	0.57	0.74	0.75	0.60	0.72	0.89	0.71
Price to Earnings (P/E)	13.38	14.38	22.47	16.07	19.23	20.89	25.40	16.15	18.49	13.91	14.62
Dividend Yield	2.71%	3.27%	1.69%	1.84%	2.00%	1.81%	1.62%	1.88%	1.46%	1.16%	1.37%
Earnings Yield	7.47%	6.95%	4.45%	6.22%	5.20%	4.79%	3.94%	6.19%	5.41%	7.19%	6.84%
Enterprise Value to Invested Capital (EV/IC)	3.91	2.04	3.42	3.11	1.34	2.05	1.97	1.71	1.97	2.28	1.99
Enterprise Value to Revenue (EV/Rev)	0.53	0.59	0.91	0.84	0.97	1.01	1.09	0.93	1.02	1.16	1.00
Enterprise Value to EBITDA (EV/EBITDA)	7.94	8.85	12.78	12.36	16.54	12.58	13.26	11.45	12.03	9.80	10.74
Enterprise Value to EBIT (EV/EBIT)	8.63	11.27	15.34	14.56	20.18	17.19	19.50	14.89	15.87	11.68	13.46
Enterprise Value to NOPAT (EV/NOPAT)	13.65	17.62	22.83	17.55	25.38	21.82	25.24	19.15	19.32	15.16	15.66
Enterprise Value to Operating Cash Flow (EV/OCF)	7.48	11.32	14.84	17.31	24.46	14.11	10.15	13.31	14.70	21.82	15.09
Enterprise Value to Free Cash Flow (EV/FCFF)	8.40	0.00	16.44	19.45	0.00	13.27	0.00	32.06	16.40	11.54	14.20
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.41	2.82	3.00	3.13	1.39	1.35	1.62	1.55	1.39	1.18	1.41
Long-Term Debt to Equity	1.32	2.67	2.93	3.01	1.38	1.30	1.58	1.45	1.38	1.13	1.21
Financial Leverage	0.60	1.46	2.35	2.54	1.50	1.23	1.37	1.50	1.40	1.22	1.24
Leverage Ratio	3.93	4.84	5.71	6.09	3.63	3.17	3.50	3.61	3.39	3.11	3.14
Compound Leverage Factor	3.65	3.90	4.59	5.05	2.77	2.41	2.42	2.79	2.58	2.61	2.43
Debt to Total Capital	58.48%	73.79%	75.00%	75.80%	58.22%	57.38%	61.84%	60.72%	58.21%	54.04%	58.47%
Short-Term Debt to Total Capital	3.85%	3.93%	1.79%	3.03%	0.67%	2.09%	1.67%	3.57%	0.76%	1.98%	8.24%
Long-Term Debt to Total Capital	54.63%	69.86%	73.21%	72.76%	57.55%	55.29%	60.17%	57.15%	57.45%	52.06%	50.22%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.39%	0.30%	0.25%	0.24%	0.25%	0.00%	0.00%
Common Equity to Total Capital	41.52%	26.21%	25.00%	24.20%	41.39%	42.32%	37.91%	39.04%	41.54%	45.96%	41.53%
Debt to EBITDA	1.86	3.70	3.30	3.37	7.68	3.74	4.35	4.18	3.65	2.38	3.20
Net Debt to EBITDA	0.71	3.03	2.64	2.89	6.81	3.37	4.06	4.01	3.48	2.27	3.12
Long-Term Debt to EBITDA	1.74	3.51	3.22	3.23	7.59	3.60	4.23	3.94	3.60	2.29	2.75
Debt to NOPAT	3.20	7.37	5.90	4.78	11.78	6.48	8.28	6.99	5.86	3.68	4.66
Net Debt to NOPAT	1.22	6.03	4.72	4.11	10.45	5.85	7.72	6.70	5.60	3.52	4.54
Long-Term Debt to NOPAT	2.99	6.98	5.76	4.59	11.65	6.25	8.06	6.58	5.79	3.55	4.00
Altman Z-Score	4.91	3.23	4.08	3.91	1.95	2.71	2.38	2.39	2.83	3.36	3.00
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.77%	0.82%	0.67%	0.63%	0.60%	0.29%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.71	1.38	1.45	1.37	1.60	1.27	1.01	0.93	1.06	0.98	0.83
Quick Ratio	1.53	1.21	1.20	1.18	1.43	1.14	0.89	0.83	0.93	0.87	0.76
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	247	-580	246	193	-1,967	487	-432	215	477	749	525
Operating Cash Flow to CapEx	1,259.09%	1,130.00%	1,820.00%	986.36%	657.14%	2,180.95%	1,641.30%	1,438.89%	2,128.00%	1,466.67%	1,372.22%
Free Cash Flow to Firm to Interest Expense	14.51	-13.18	4.74	4.39	-37.11	5.41	-3.54	2.05	4.04	6.24	4.17
Operating Cash Flow to Interest Expense	16.29	5.14	5.25	4.93	3.47	5.09	6.19	4.93	4.51	3.30	3.92
Operating Cash Flow Less CapEx to Interest Expense	15.00	4.68	4.96	4.43	2.94	4.86	5.81	4.59	4.30	3.08	3.63
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	2.74	2.46	2.13	2.16	1.40	1.38	1.35	1.29	1.36	1.37	1.42
Accounts Receivable Turnover	6.67	7.32	7.57	7.34	5.40	5.94	6.85	7.48	7.90	8.05	7.82
Inventory Turnover	56.35	57.84	57.60	58.17	59.08	71.81	77.33	92.04	100.98	0.00	0.00
Fixed Asset Turnover	65.29	66.38	67.82	73.62	56.82	65.76	70.91	71.10	80.25	81.36	76.71
Accounts Payable Turnover	10.89	11.72	11.77	11.14	9.85	11.55	12.00	11.58	11.03	11.04	11.00
Days Sales Outstanding (DSO)	54.73	49.87	48.23	49.70	67.53	61.48	53.31	48.80	46.22	45.36	46.70
Days Inventory Outstanding (DIO)	6.48	6.31	6.34	6.27	6.18	5.08	4.72	3.97	3.61	0.00	0.00
Days Payable Outstanding (DPO)	33.52	31.13	31.00	32.77	37.07	31.59	30.42	31.53	33.09	33.07	33.19
Cash Conversion Cycle (CCC)	27.69	25.04	23.57	23.20	36.64	34.97	27.61	21.23	16.74	12.28	13.51
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	530	1,255	1,186	1,207	3,351	3,160	3,896	4,041	3,969	3,790	3,741
Invested Capital Turnover	6.73	4.83	3.64	3.72	2.04	1.96	2.00	1.86	1.92	1.92	1.99
Increase / (Decrease) in Invested Capital	-95	725	-69	21	2,144	-191	736	145	-72	-179	-49
Enterprise Value (EV)	2,072	2,558	4,050	3,757	4,500	6,464	7,663	6,894	7,822	8,642	7,457
Market Capitalization	1,887	1,683	3,213	2,877	2,634	4,721	5,309	4,472	5,547	6,637	5,293
Book Value per Share	$7.55	$8.36	$7.95	$7.65	$34.90	$24.55	$26.48	$28.43	$31.01	$34.29	$32.26
Tangible Book Value per Share	($0.79)	($15.48)	($16.27)	($16.72)	($33.80)	($24.83)	($40.93)	($42.61)	($40.75)	($37.65)	($42.00)
Total Capital	831	1,450	1,396	1,351	3,588	3,348	4,067	4,147	4,078	3,884	3,797
Total Debt	486	1,070	1,047	1,024	2,089	1,921	2,515	2,518	2,374	2,099	2,220
Total Long-Term Debt	454	1,013	1,022	983	2,065	1,851	2,447	2,370	2,343	2,022	1,907
Net Debt	185	875	837	880	1,852	1,733	2,344	2,412	2,265	2,005	2,164
Capital Expenditures (CapEx)	22	20	15	22	28	21	46	36	25	27	36
Debt-free, Cash-free Net Working Capital (DFCFNWC)	121	126	93	152	323	184	-89	-47	-7.00	-44	15
Debt-free Net Working Capital (DFNWC)	422	321	303	296	560	372	82	59	102	50	71
Net Working Capital (NWC)	390	264	278	255	536	302	14	-89	71	-27	-242
Net Nonoperating Expense (NNE)	11	28	34	35	40	67	93	81	102	93	114
Net Nonoperating Obligations (NNO)	185	875	837	880	1,852	1,733	2,344	2,412	2,265	2,005	2,164
Total Depreciation and Amortization (D&A)	21	62	53	46	49	138	185	139	157	142	140
Debt-free, Cash-free Net Working Capital to Revenue	3.11%	2.92%	2.09%	3.41%	6.93%	2.88%	-1.26%	-0.64%	-0.09%	-0.59%	0.20%
Debt-free Net Working Capital to Revenue	10.86%	7.44%	6.82%	6.65%	12.02%	5.83%	1.16%	0.80%	1.32%	0.67%	0.95%
Net Working Capital to Revenue	10.04%	6.12%	6.26%	5.73%	11.50%	4.73%	0.20%	-1.20%	0.92%	-0.36%	-3.24%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($4.36)	$2.55	$3.33	$4.13	$3.16	$3.87	$3.60	$4.81	$5.42	$8.98	$7.23
Adjusted Weighted Average Basic Shares Outstanding	74.13M	44.78M	43.57M	42.28M	59.32M	57.84M	58.07M	56.05M	54.20M	51.65M	47.74M
Adjusted Diluted Earnings per Share	($4.36)	$2.47	$3.22	$4.02	$3.11	$3.83	$3.56	$4.77	$5.38	$8.88	$7.17
Adjusted Weighted Average Diluted Shares Outstanding	74.13M	44.78M	43.57M	42.28M	59.32M	57.84M	58.07M	56.05M	54.20M	51.65M	47.74M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$4.13	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	74.13M	44.78M	43.57M	42.28M	59.32M	57.84M	58.07M	56.05M	54.20M	51.65M	47.74M
Normalized Net Operating Profit after Tax (NOPAT)	152	145	184	214	247	335	346	402	405	385	476
Normalized NOPAT Margin	3.91%	3.36%	4.15%	4.81%	5.29%	5.25%	4.90%	5.44%	5.25%	5.18%	6.37%
Pre Tax Income Margin	5.74%	4.24%	4.77%	4.80%	3.65%	4.48%	3.84%	4.84%	4.87%	8.33%	5.72%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	14.12	5.16	5.08	5.86	4.21	4.18	3.22	4.41	4.18	6.17	4.40
NOPAT to Interest Expense	8.93	3.30	3.41	4.87	3.35	3.29	2.49	3.43	3.43	4.75	3.78
EBIT Less CapEx to Interest Expense	12.82	4.70	4.79	5.36	3.68	3.94	2.84	4.07	3.97	5.94	4.11
NOPAT Less CapEx to Interest Expense	7.63	2.84	3.12	4.37	2.82	3.06	2.11	3.09	3.22	4.53	3.49
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	36.88%	47.01%	37.76%	30.17%	37.96%	41.05%	42.18%	31.54%	27.39%	16.56%	20.72%
Augmented Payout Ratio	142.55%	105.98%	163.64%	134.08%	89.78%	127.07%	58.29%	112.54%	115.51%	96.65%	174.86%

This table displays calculated financial ratios and metrics derived from Science Applications International's official financial filings.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	7/29/2022	10/28/2022	2/3/2023	5/5/2023	8/4/2023	11/3/2023	2/2/2024	5/3/2024	8/2/2024	11/1/2024	1/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-0.27%	0.58%	10.44%	1.60%	-2.57%	-0.73%	-11.74%	-8.93%	1.91%	4.27%	5.81%
EBITDA Growth	3.13%	10.88%	26.02%	17.18%	142.42%	7.36%	-25.16%	-14.14%	-58.75%	10.29%	48.28%
EBIT Growth	-6.72%	14.04%	39.76%	27.05%	191.20%	8.46%	-31.03%	-16.77%	-64.01%	12.06%	70.00%
NOPAT Growth	-3.58%	15.68%	58.68%	28.47%	174.12%	9.64%	-38.35%	-15.12%	-59.33%	15.38%	96.91%
Net Income Growth	-9.76%	12.68%	70.45%	32.43%	233.78%	16.25%	-48.00%	-21.43%	-67.21%	13.98%	151.28%
EPS Growth	-7.80%	18.85%	76.32%	38.76%	250.77%	21.38%	-42.54%	-17.32%	-65.35%	21.02%	157.14%
Operating Cash Flow Growth	53.26%	-4.48%	40.78%	-30.51%	6.38%	-21.09%	-56.55%	19.51%	-8.00%	41.58%	82.54%
Free Cash Flow Firm Growth	352.89%	249.86%	321.85%	572.34%	244.72%	152.98%	38.08%	-124.12%	-74.26%	-46.24%	-27.88%
Invested Capital Growth	-1.28%	-0.82%	-1.78%	-12.95%	-6.18%	-5.88%	-4.51%	7.45%	-0.64%	-1.46%	-1.29%
Revenue Q/Q Growth	-8.27%	4.26%	3.09%	3.05%	-12.03%	6.22%	-8.34%	6.33%	-1.57%	8.69%	-6.98%
EBITDA Q/Q Growth	1.23%	-1.21%	-4.91%	24.03%	109.42%	-56.25%	-33.71%	47.75%	0.61%	16.97%	-10.88%
EBIT Q/Q Growth	2.46%	4.00%	-10.77%	33.62%	134.84%	-61.26%	-43.26%	79.17%	1.55%	20.61%	-13.92%
NOPAT Q/Q Growth	0.00%	9.28%	-2.15%	20.14%	113.37%	-56.29%	-44.98%	65.42%	2.22%	24.01%	-6.10%
Net Income Q/Q Growth	0.00%	8.11%	-6.25%	30.67%	152.04%	-62.35%	-58.06%	97.44%	5.19%	30.86%	-7.55%
EPS Q/Q Growth	0.78%	11.54%	-7.59%	33.58%	154.75%	-61.40%	-56.25%	92.21%	6.76%	34.81%	-7.04%
Operating Cash Flow Q/Q Growth	19.49%	-9.22%	13.28%	-43.45%	82.93%	-32.67%	-37.62%	55.56%	40.82%	3.62%	-19.58%
Free Cash Flow Firm Q/Q Growth	208.53%	-6.67%	26.34%	269.12%	-20.79%	-31.51%	-31.04%	-164.49%	184.52%	43.05%	-7.49%
Invested Capital Q/Q Growth	-0.96%	0.00%	-1.17%	-11.06%	6.74%	0.32%	0.26%	0.08%	-1.29%	-0.51%	0.43%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	11.96%	11.58%	11.28%	11.59%	12.11%	12.08%	11.05%	11.53%	11.55%	11.99%	12.62%
EBITDA Margin	9.01%	8.54%	7.88%	9.42%	22.42%	9.23%	6.68%	8.88%	9.08%	9.77%	9.36%
Operating Margin	6.83%	6.97%	6.00%	7.74%	20.29%	7.55%	4.55%	7.09%	7.37%	8.10%	7.51%
EBIT Margin	6.83%	6.81%	5.89%	7.64%	20.40%	7.44%	4.61%	6.98%	7.21%	8.00%	7.40%
Profit (Net Income) Margin	4.04%	4.19%	3.81%	4.83%	13.85%	4.91%	2.25%	4.17%	4.46%	5.36%	5.33%
Tax Burden Percent	77.89%	80.00%	88.24%	79.67%	73.73%	81.58%	81.25%	81.05%	81.00%	84.13%	91.59%
Interest Burden Percent	76.00%	76.92%	73.28%	79.35%	92.03%	80.85%	60.00%	73.64%	76.34%	79.75%	78.68%
Effective Tax Rate	22.11%	20.00%	11.76%	20.33%	26.27%	18.42%	18.75%	18.95%	19.00%	15.87%	8.41%
Return on Invested Capital (ROIC)	9.88%	10.39%	10.18%	12.58%	29.56%	12.12%	7.09%	11.40%	11.60%	13.39%	13.66%
ROIC Less NNEP Spread (ROIC-NNEP)	8.90%	9.27%	8.93%	11.30%	28.63%	11.01%	5.91%	9.90%	10.24%	11.99%	12.30%
Return on Net Nonoperating Assets (RNNOA)	13.03%	13.11%	12.53%	14.35%	35.11%	13.35%	7.23%	11.10%	11.94%	14.16%	15.25%
Return on Equity (ROE)	22.91%	23.50%	22.71%	26.93%	64.67%	25.47%	14.32%	22.51%	23.54%	27.56%	28.91%
Cash Return on Invested Capital (CROIC)	10.01%	9.92%	11.91%	25.25%	21.76%	21.68%	19.31%	7.86%	11.17%	12.49%	13.95%
Operating Return on Assets (OROA)	8.87%	8.87%	8.05%	10.13%	27.70%	10.12%	6.32%	9.05%	9.63%	10.79%	10.48%
Return on Assets (ROA)	5.25%	5.46%	5.20%	6.41%	18.80%	6.67%	3.08%	5.40%	5.95%	7.24%	7.55%
Return on Common Equity (ROCE)	22.77%	23.36%	22.57%	26.85%	64.49%	25.40%	14.28%	22.51%	23.54%	27.56%	28.91%
Return on Equity Simple (ROE_SIMPLE)	16.01%	16.13%	0.00%	19.33%	27.13%	28.06%	0.00%	25.92%	17.85%	18.80%	0.00%
Net Operating Profit after Tax (NOPAT)	97	106	104	125	267	117	64	106	109	135	126
NOPAT Margin	5.32%	5.57%	5.29%	6.17%	14.96%	6.16%	3.70%	5.75%	5.97%	6.81%	6.88%
Net Nonoperating Expense Percent (NNEP)	0.97%	1.12%	1.25%	1.28%	0.93%	1.11%	1.18%	1.51%	1.36%	1.41%	1.36%
Return On Investment Capital (ROIC_SIMPLE)	-	-	2.55%	-	-	-	1.65%	-	-	-	3.33%
Cost of Revenue to Revenue	88.04%	88.42%	88.72%	88.41%	87.89%	87.92%	88.95%	88.47%	88.45%	88.01%	87.38%
SG&A Expenses to Revenue	5.08%	4.56%	5.18%	4.14%	4.93%	4.59%	6.56%	4.60%	4.24%	4.20%	5.11%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	5.13%	4.61%	5.28%	3.85%	-8.18%	4.54%	6.51%	4.44%	4.18%	3.90%	5.11%
Earnings before Interest and Taxes (EBIT)	125	130	116	155	364	141	80	129	131	158	136
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	165	163	155	191	400	175	116	164	165	193	172
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.20	3.43	3.27	3.19	3.50	3.18	3.72	3.85	3.88	4.44	3.36
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.70	0.77	0.72	0.70	0.84	0.76	0.89	0.93	0.86	0.97	0.71
Price to Earnings (P/E)	20.20	21.47	18.49	16.60	12.93	11.34	13.91	14.85	21.73	23.64	14.62
Dividend Yield	1.57%	1.41%	1.46%	1.49%	1.23%	1.35%	1.16%	1.13%	1.20%	1.02%	1.37%
Earnings Yield	4.95%	4.66%	5.41%	6.02%	7.73%	8.82%	7.19%	6.73%	4.60%	4.23%	6.84%
Enterprise Value to Invested Capital (EV/IC)	1.90	2.02	1.97	2.08	2.22	2.05	2.28	2.32	2.25	2.49	1.99
Enterprise Value to Revenue (EV/Rev)	1.02	1.08	1.02	0.95	1.09	1.01	1.16	1.21	1.15	1.26	1.00
Enterprise Value to EBITDA (EV/EBITDA)	12.75	13.20	12.03	10.84	9.18	8.42	9.80	10.30	13.58	14.54	10.74
Enterprise Value to EBIT (EV/EBIT)	17.18	17.62	15.87	13.97	10.95	10.00	11.68	12.33	17.51	18.63	13.46
Enterprise Value to NOPAT (EV/NOPAT)	21.63	22.10	19.32	16.99	13.99	12.74	15.16	15.99	21.29	22.42	15.66
Enterprise Value to Operating Cash Flow (EV/OCF)	15.37	16.54	14.70	14.81	16.59	16.23	21.82	21.38	21.05	20.99	15.09
Enterprise Value to Free Cash Flow (EV/FCFF)	18.85	20.27	16.40	7.67	9.90	9.18	11.54	30.61	20.07	19.79	14.20
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.49	1.40	1.39	1.40	1.24	1.24	1.18	1.18	1.33	1.34	1.41
Long-Term Debt to Equity	1.49	1.39	1.38	1.38	1.20	1.20	1.13	1.13	1.21	1.20	1.21
Financial Leverage	1.46	1.41	1.40	1.27	1.23	1.21	1.22	1.12	1.17	1.18	1.24
Leverage Ratio	3.52	3.46	3.39	3.49	3.24	3.20	3.11	3.25	3.15	3.18	3.14
Compound Leverage Factor	2.68	2.66	2.48	2.77	2.98	2.59	1.87	2.39	2.40	2.53	2.47
Debt to Total Capital	59.83%	58.32%	58.21%	58.40%	55.27%	55.32%	54.04%	54.22%	57.15%	57.25%	58.47%
Short-Term Debt to Total Capital	0.00%	0.37%	0.76%	1.13%	1.50%	1.69%	1.98%	2.34%	5.20%	5.83%	8.24%
Long-Term Debt to Total Capital	59.83%	57.95%	57.45%	57.27%	53.76%	53.63%	52.06%	51.87%	51.95%	51.42%	50.22%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.24%	0.25%	0.25%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	39.93%	41.44%	41.54%	41.60%	44.73%	44.68%	45.96%	45.78%	42.85%	42.75%	41.53%
Debt to EBITDA	4.12	3.86	3.65	3.50	2.49	2.46	2.38	2.44	3.50	3.38	3.20
Net Debt to EBITDA	3.95	3.78	3.48	2.88	2.11	2.12	2.27	2.38	3.42	3.31	3.12
Long-Term Debt to EBITDA	4.12	3.84	3.60	3.44	2.43	2.38	2.29	2.33	3.18	3.04	2.75
Debt to NOPAT	6.98	6.47	5.86	5.49	3.80	3.72	3.68	3.78	5.48	5.22	4.66
Net Debt to NOPAT	6.70	6.32	5.60	4.52	3.22	3.21	3.52	3.69	5.36	5.11	4.54
Long-Term Debt to NOPAT	6.98	6.43	5.79	5.39	3.70	3.60	3.55	3.62	4.98	4.69	4.00
Altman Z-Score	2.43	2.54	2.60	2.43	2.95	2.73	2.95	3.01	2.89	3.06	2.74
Noncontrolling Interest Sharing Ratio	0.61%	0.60%	0.60%	0.30%	0.29%	0.28%	0.29%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.07	1.01	1.06	1.08	1.14	1.13	0.98	0.95	0.85	0.87	0.83
Quick Ratio	0.95	0.90	0.93	0.91	1.08	1.08	0.87	0.85	0.77	0.80	0.76
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	149	139	176	650	515	353	243	-157	133	190	175
Operating Cash Flow to CapEx	2,014.29%	2,133.33%	2,071.43%	1,366.67%	2,500.00%	2,525.00%	572.73%	1,633.33%	2,300.00%	1,588.89%	766.67%
Free Cash Flow to Firm to Interest Expense	4.98	4.65	5.68	20.32	17.76	13.06	7.60	-4.61	4.28	5.93	6.05
Operating Cash Flow to Interest Expense	4.70	4.27	4.68	2.56	5.17	3.74	1.97	2.88	4.45	4.47	3.97
Operating Cash Flow Less CapEx to Interest Expense	4.47	4.07	4.45	2.38	4.97	3.59	1.63	2.71	4.26	4.19	3.45
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.30	1.30	1.36	1.33	1.36	1.36	1.37	1.30	1.34	1.35	1.42
Accounts Receivable Turnover	7.15	6.94	7.90	7.37	7.71	7.42	8.05	7.53	7.66	7.26	7.82
Inventory Turnover	0.00	0.00	100.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	75.07	75.94	80.25	82.30	83.12	83.42	81.36	78.95	78.89	78.49	76.71
Accounts Payable Turnover	7.60	7.85	11.03	8.40	8.12	8.17	11.04	8.80	8.85	8.40	11.00
Days Sales Outstanding (DSO)	51.05	52.58	46.22	49.52	47.33	49.20	45.36	48.47	47.62	50.26	46.70
Days Inventory Outstanding (DIO)	0.00	0.00	3.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	48.01	46.51	33.09	43.47	44.93	44.70	33.07	41.46	41.26	43.46	33.19
Cash Conversion Cycle (CCC)	3.04	6.07	16.74	6.05	2.39	4.50	12.28	7.01	6.36	6.81	13.51
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	4,016	4,016	3,969	3,530	3,768	3,780	3,790	3,793	3,744	3,725	3,741
Invested Capital Turnover	1.86	1.86	1.92	2.04	1.98	1.97	1.92	1.98	1.94	1.97	1.99
Increase / (Decrease) in Invested Capital	-52	-33	-72	-525	-248	-236	-179	263	-24	-55	-49
Enterprise Value (EV)	7,626	8,107	7,822	7,347	8,379	7,757	8,642	8,807	8,422	9,277	7,457
Market Capitalization	5,253	5,777	5,547	5,394	6,454	5,805	6,637	6,773	6,303	7,164	5,293
Book Value per Share	$29.51	$30.58	$31.01	$31.22	$34.33	$34.53	$34.29	$34.06	$31.72	$32.55	$32.26
Tangible Book Value per Share	($41.97)	($41.09)	($40.75)	($39.46)	($36.49)	($36.76)	($37.65)	($37.89)	($40.25)	($41.32)	($42.00)
Total Capital	4,115	4,069	4,078	4,067	4,120	4,091	3,884	3,842	3,792	3,771	3,797
Total Debt	2,462	2,373	2,374	2,375	2,277	2,263	2,099	2,083	2,167	2,159	2,220
Total Long-Term Debt	2,462	2,358	2,343	2,329	2,215	2,194	2,022	1,993	1,970	1,939	1,907
Net Debt	2,363	2,320	2,265	1,953	1,925	1,952	2,005	2,034	2,119	2,113	2,164
Capital Expenditures (CapEx)	7.00	6.00	7.00	6.00	6.00	4.00	11	6.00	6.00	9.00	15
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-19	-21	-7.00	-254	-118	-80	-44	-22	-40	-3.00	15
Debt-free Net Working Capital (DFNWC)	80	32	102	168	234	231	50	27	8.00	43	71
Net Working Capital (NWC)	80	17	71	122	172	162	-27	-63	-189	-177	-242
Net Nonoperating Expense (NNE)	23	26	29	27	20	24	25	29	28	29	28
Net Nonoperating Obligations (NNO)	2,363	2,320	2,265	1,838	1,925	1,952	2,005	2,034	2,119	2,113	2,164
Total Depreciation and Amortization (D&A)	40	33	39	36	36	34	36	35	34	35	36
Debt-free, Cash-free Net Working Capital to Revenue	-0.25%	-0.28%	-0.09%	-3.28%	-1.53%	-1.04%	-0.59%	-0.30%	-0.55%	-0.04%	0.20%
Debt-free Net Working Capital to Revenue	1.07%	0.43%	1.32%	2.17%	3.04%	3.01%	0.67%	0.37%	0.11%	0.58%	0.95%
Net Working Capital to Revenue	1.07%	0.23%	0.92%	1.58%	2.24%	2.11%	-0.36%	-0.87%	-2.59%	-2.40%	-3.24%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.31	$1.45	$1.36	$1.80	$4.60	$1.79	$0.79	$1.49	$1.59	$2.15	$2.00
Adjusted Weighted Average Basic Shares Outstanding	55.13M	54.63M	54.20M	53.68M	52.94M	52.06M	51.65M	51.23M	49.52M	48.88M	47.74M
Adjusted Diluted Earnings per Share	$1.30	$1.45	$1.34	$1.79	$4.56	$1.76	$0.77	$1.48	$1.58	$2.13	$1.98
Adjusted Weighted Average Diluted Shares Outstanding	55.13M	54.63M	54.20M	53.68M	52.94M	52.06M	51.65M	51.23M	49.52M	48.88M	47.74M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	55.13M	54.63M	54.20M	53.68M	52.94M	52.06M	51.65M	51.23M	49.52M	48.88M	47.74M
Normalized Net Operating Profit after Tax (NOPAT)	98	107	104	120	94	117	64	106	109	135	126
Normalized NOPAT Margin	5.36%	5.62%	5.29%	5.93%	5.29%	6.16%	3.70%	5.75%	5.97%	6.81%	6.88%
Pre Tax Income Margin	5.19%	5.24%	4.32%	6.07%	18.78%	6.02%	2.76%	5.14%	5.50%	6.38%	5.82%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.17	4.33	3.74	4.84	12.55	5.22	2.50	3.79	4.23	4.94	4.69
NOPAT to Interest Expense	3.25	3.55	3.36	3.91	9.20	4.32	2.01	3.12	3.50	4.21	4.36
EBIT Less CapEx to Interest Expense	3.93	4.13	3.52	4.66	12.34	5.07	2.16	3.62	4.03	4.66	4.17
NOPAT Less CapEx to Interest Expense	3.01	3.35	3.13	3.72	9.00	4.17	1.66	2.95	3.31	3.93	3.84
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	33.08%	31.99%	27.39%	25.69%	16.60%	15.79%	16.56%	17.11%	26.55%	25.08%	20.72%
Augmented Payout Ratio	140.68%	134.93%	115.51%	108.56%	78.40%	84.41%	96.65%	104.17%	197.59%	194.72%	174.86%

Frequently Asked Questions About Science Applications International's Financials

When does Science Applications International's fiscal year end?

According to the most recent income statement we have on file, Science Applications International's financial year ends in January. Their financial year 2025 ended on January 31, 2025.

How has Science Applications International's net income changed over the last 10 years?

Science Applications International's net income appears to be on an upward trend, with a most recent value of $362 million in 2025, rising from $141 million in 2015. The previous period was $477 million in 2024.

What is Science Applications International's operating income?

Science Applications International's total operating income in 2025 was $563 million, based on the following breakdown:

Total Gross Profit: $892 million
Total Operating Expenses: $329 million

How has Science Applications International revenue changed over the last 10 years?

Over the last 10 years, Science Applications International's total revenue changed from $3.89 billion in 2015 to $7.48 billion in 2025, a change of 92.5%.

How much debt does Science Applications International have?

Science Applications International's total liabilities were at $3.67 billion at the end of 2025, a 4.0% increase from 2024, and a 251.4% increase since 2015.

How much cash does Science Applications International have?

In the past 10 years, Science Applications International's cash and equivalents has ranged from $0.00 in 2018 to $301 million in 2015, and is currently $56 million as of their latest financial filing in 2025.

How has Science Applications International's book value per share changed over the last 10 years?

Over the last 10 years, Science Applications International's book value per share changed from 7.55 in 2015 to 32.26 in 2025, a change of 327.2%.

Related Companies

This page (NASDAQ:SAIC) was last updated on 6/9/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Science Applications International (SAIC) Financials

Frequently Asked Questions About Science Applications International's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Science Applications International (SAIC) Financials

Annual Income Statements for Science Applications International

Quarterly Income Statements for Science Applications International

Annual Cash Flow Statements for Science Applications International

Quarterly Cash Flow Statements for Science Applications International

Annual Balance Sheets for Science Applications International

Quarterly Balance Sheets for Science Applications International

Annual Metrics And Ratios for Science Applications International

Quarterly Metrics And Ratios for Science Applications International

Frequently Asked Questions About Science Applications International's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools